Impaired glucose tolerance
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
When challenged with a high-fat diet, conditional deletion of TCF7L2 in adipocytes led to impaired glucose tolerance, impaired insulin sensitivity, promoted weight gain, and increased adipose tissue mass.
|
30948248 |
2019 |
Impaired glucose tolerance
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
Inactivation of TCF7L2 protein by removing the high-mobility group (HMG)-box DNA binding domain in mature adipocytes in vivo leads to whole-body glucose intolerance and hepatic insulin resistance.
|
29317436 |
2018 |
Impaired glucose tolerance
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Transgenic mice in which Tcf7l2 was selectively inactivated in their pancreatic pericytes exhibited impaired glucose tolerance due to compromised β-cell function and glucose-stimulated insulin secretion.
|
29246974 |
2018 |
Impaired glucose tolerance
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
Interestingly, the persistent overexpression of Tcf7l2 in non-pancreatic tissues results in a significant worsening in glucose tolerance in vivo, indicating that Tcf7l2 overexpression in beta cells does not account for the glucose intolerance in the Tcf7l2 overexpression mouse model.
|
25398947 |
2015 |
Impaired glucose tolerance
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
Finally, haploinsufficiency of TCF7L2 in mice displayed higher glucose levels and impaired glucose tolerance, which were rescued by hepatic expression of a nuclear isoform of TCF7L2 at the physiological level.
|
23028378 |
2012 |
Impaired glucose tolerance
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
Confirming these observations, transgenic mice harboring multiple Tcf7l2 copies and overexpressing this gene display reciprocal phenotypes, including glucose intolerance.
|
21673050 |
2011 |
Impaired glucose tolerance
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
Despite no associations between incidence of glucose intolerance and SNPs of the TCF7L2 gene in Japanese-Brazilians, we found that carriers of the CT genotype for rs7903146 had significantly lower insulin levels 2 h after a 75-g glucose load than carriers of the CC genotype.
|
21399856 |
2011 |
Impaired glucose tolerance
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
Diabetes-associated variants in CDKAL1, CDKN2B, HHEX/IDE, IGF2BP2, KCNJ11, SLC30A8 and TCF7L2 are associated with physiological alterations leading to T2DM, such as glucose intolerance, impaired insulin secretion or insulin resistance, supporting their role in the disease aetiology.
|
19082521 |
2009 |
Impaired glucose tolerance
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
In the total population, the TCF7L2 and IGF2BP2 variants most strongly associated with increased risk for type 2 diabetes/IGT and increased AUC for glucose, while the CDKAL1 polymorphism associated with decreased AUC for insulin.
|
19258437 |
2009 |
Impaired glucose tolerance
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Evidence for association between polycystic ovary syndrome (PCOS) and TCF7L2 and glucose intolerance in women with PCOS and TCF7L2.
|
19351735 |
2009 |
Impaired glucose tolerance
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
In adults, the TCF7L2 rs7903146 T allele, commonly associated with type 2 diabetes (T2D), has been also associated with a lower body mass index (BMI) in T2D individuals and with a smaller waist circumference in subjects with impaired glucose tolerance.
|
17593304 |
2007 |
Impaired glucose tolerance
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
Common variants in TCF7L2 seem to be associated with an increased risk of diabetes among persons with impaired glucose tolerance.
|
16855264 |
2006 |